Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 8/20 | 0.66 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.66 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.60 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.60 |
| ▸ | PYGB | P11216 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2316511 | 1.00 | LGALS3 (0.66) | LGALS3LGALS1LGALS9LGALS8PYGB | |
| SCHEMBL5615593 | 1.00 | LGALS3 (0.66) | LGALS3LGALS1LGALS9LGALS8PYGB | |
| SCHEMBL2319442 | 1.00 | LGALS3 (0.66) | LGALS3LGALS1LGALS9LGALS8PYGB | |
| SCHEMBL9705266 | 0.89 | LGALS3 (0.61) | LGALS3LGALS1LGALS9LGALS8PYGB | |
| SCHEMBL4346094 | 0.89 | LGALS3 (0.61) | LGALS3LGALS1LGALS9LGALS8PYGB | |
| SCHEMBL15137456 | 0.86 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8GAA | |
| SCHEMBL1668605 | 0.86 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8GAA | |
| SCHEMBL3885456 | 0.86 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8GAA | |
| SCHEMBL5577129 | 0.86 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8GAA | |
| SCHEMBL3171119 | 0.86 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113004375-A | Small molecular protein for efficiently mediating recombinant polypeptide to form inclusion body | 华南农业大学 | 2021-06-22 | — | — | CN | claimed |
| US-20060073595-A1 | Recombinant Adenoviruses which function as helper viruses to gutted Ad viruses lacking viral coding sequences; gene therapy | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2006-04-06 | — | — | US | claimed |
| WO-2003027271-A2 | REGULATION OF ADENOVIRUS DNA PACKAGING BY IPTG | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 2003-04-03 | — | — | WO | claimed |
| CN-1355321-A | Process for screening ApoAI from human all-genome Cosmid library by PCR technique to express all genes | SHANGHAI MEDICINE GROUP CO (CN) | 2002-06-26 | — | — | CN | claimed |
| WO-2022001121-A1 | LYSINE DECARBOXYLASE FOR SYNTHESIZING PENTANEDIAMINE AND APPLICATION THEREOF | 中国科学院过程工程研究所 | 2022-01-06 | — | — | WO | disclosed |
| EP-3561049-A1 | GENETICALLY ENGINEERED BACTERIUM OF COEXPRESSING CYCLOHEXANONE MONOOXYGENASE AND ISOPROPANOL DEHYDROGENASE AND USE THEREOF | Zhejiang Jingxin Pharmaceutical Co., Ltd. (CN) | 2019-10-30 | — | — | EP | disclosed |
| CN-110359297-A | Method for preparing dyed biopolymers and products thereof | 尚科纺织企业工业及贸易公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110234355-A | Monomer human IgG1 Fc and bispecific antibody | 时迈药业 | 2019-09-13 | — | — | CN | disclosed |
| CN-109789185-A | For treating the albumen containing CAS9 of eye disease and the pharmaceutical composition of guide RNA | 基础科学研究院 | 2019-05-21 | — | — | CN | disclosed |
| CN-109477120-A | Vetiver | 弗门尼舍有限公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-108841848-A | expression system | 富士胶片戴奥辛思生物技术英国有限公司 | 2018-11-20 | — | — | CN | disclosed |
| CN-102690834-B | Expression system | 富士胶片戴奥辛思生物技术英国有限公司 | 2018-09-04 | — | — | CN | disclosed |
| EP-0635061-A1 | A METHOD OF LIMITING THE SURVIVAL OF GENETICALLY ENGINEERED MICROORGANISMS IN THEIR ENVIRONMENT | GX BioSystems A/S (DK) | 1995-01-25 | — | — | EP | disclosed |
| EP-0506963-A1 | PRODUCTION OF HUMAN BASIC FGF MUTEIN | Takeda Chemical Industries, Ltd. (JP) | 1992-10-07 | — | — | EP | disclosed |
| EP-0451194-A4 | RECOMBINANT DNA MOLECULES, HOSTS, PROCESSES AND HUMAN SOMATOMEDIN CARRIER PROTEIN-LIKE POLYPEPTIDES | — | 1992-09-02 | — | — | EP | disclosed |
| EP-0451194-A1 | RECOMBINANT DNA MOLECULES, HOSTS, PROCESSES AND HUMAN SOMATOMEDIN CARRIER PROTEIN-LIKE POLYPEPTIDES. | BIOGROWTH INC (US) | 1991-10-16 | — | — | EP | disclosed |
| WO-1991009126-A1 | PRODUCTION OF HUMAN BASIC FGF MUTEIN | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-06-27 | — | — | WO | disclosed |
| WO-1990006950-A1 | RECOMBINANT DNA MOLECULES, HOSTS, PROCESSES AND HUMAN SOMATOMEDIN CARRIER PROTEIN-LIKE POLYPEPTIDES | BIOGROWTH, INC. (US) | 1990-06-28 | — | — | WO | disclosed |
| EP-0375438-A2 | Recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides | CELTRIX PHARMACEUTICALS, INC. (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0309746-A1 | Antimalaria vaccines | F. HOFFMANN-LA ROCHE AG (CH) | 1989-04-05 | — | — | EP | disclosed |